Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Oncology dealmaking

2.1. Introduction
2.2. Oncology partnering over the years
2.3. Oncology partnering by deal type
2.4. Oncology partnering by industry sector
2.5. Oncology partnering by stage of development
2.6. Oncology partnering by technology type
2.7. Oncology partnering by therapeutic indication

Chapter 3 –Financial deal terms for Oncology partnering

3.1. Introduction
3.2. Disclosed financials terms for Oncology partnering
3.3. Oncology partnering headline values
3.4. Oncology deal upfront payments
3.5. Oncology deal milestone payments
3.6. Oncology royalty rates

Chapter 4 – Leading Oncology deals and dealmakers

4.1. Introduction
4.2. Most active in Oncology partnering
4.3. List of most active dealmakers in Oncology
4.4. Top Oncology deals by value

Chapter 5 – Oncology contract document directory

5.1. Introduction
5.2. Oncology partnering deals where contract document available

Chapter 6 – Oncology dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Oncology therapeutic target
Appendices
Appendix 1 – Directory of Oncology deals by company A-Z since 2014
Appendix 2 – Directory of Oncology deals by deal type since 2014
Appendix 3 – Directory of Oncology deals by stage of development since 2014
Appendix 4 – Directory of Oncology deals by technology type since 2014
Further reading on dealmaking
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Oncology partnering since 2014
Figure 2: Oncology partnering by deal type since 2014
Figure 3: Oncology partnering by industry sector since 2014
Figure 4: Oncology partnering by stage of development since 2014
Figure 5: Oncology partnering by technology type since 2014
Figure 6: Oncology partnering by indication since 2014
Figure 7: Oncology deals with a headline value
Figure 8: Oncology deals with upfront payment values
Figure 9: Oncology deals with milestone payment
Figure 10: Oncology deals with royalty rates
Figure 11: Active Oncology dealmaking activity since 2014
Figure 12: Top Oncology deals by value since 2014

Companies mentioned

1ST Biotherapeutics, 2A, 2X Oncology, 3B Pharmaceuticals, 3DMed, 3D Signatures, 3M Drug Delivery Systems, 3PrimeDx, 3SBio, 4D Pharma, 4SC, 14M Genomics, 20/20 GeneSystems, 48Hour Discovery, 1717 Life Science Ventures, A*STAR Agency for Science, Technology and Research, A*STAR Bioinformatics Institute, A*STAR Bioprocessing Technology Institute, A*STAR Genome Institute of Singapore, A*STAR’ Institute of Molecular and Cell Biology, AADi, aaiPharma, AB Analitica, Abbisko Therapeutics, Abbott Laboratories, Abbvie, Abcam, AbClon, Abcodia, Abcuro, Abilita Bio, Ability Pharmaceuticals, Abingdon Health, Abingworth Management, ABL Bio, Ablynx, Abpro, Abramson Cancer Center, Abreos Biosciences, Absorption Systems, ABX, Abzena, Academia Sinica, Academic and Community Cancer Research United, Academic Drug Discovery Consortium, Accelovance, Accenture, Access Health, Access Pharmaceuticals, Accord Healthcare, AccuGenomics, Accuray, Accu Reference Medical Laboratory, Accurexa, Accutest, ACEA Biosciences, AceCGT Life Science, Acentrus Specialty, Acerta Pharma, Acoustic MedSystems, Acrotech Biopharma, ACT Biotech, Actelion, ACT Genomics, Actinium Pharmaceuticals, Actinobac Biomed, Active Biotech, ACT Onocology, Acuity Pharmaceuticals, Adagene, Adaptiiv, Adaptimmune, Adaptive Biotechnologies, ADC Therapeutics, Adimab, Adlai Nortye, Admera Health, AdoRx Therapeutics, ADT Pharmaceuticals, Adult Brain Tumor Consortium, Aduro BioTech, AdvaMed, Advanced Accelerator Applications, Advanced Biological Laboratories, Advanced BioScience Laboratories, Advanced Cell Diagnostics, Advanced Cooling Therapy, Advanced Medical Isotope, Advanced Nuclear Medicine Ingredients, Advanced Proteome Therapeutics, Advanced Radiation Therapy, Advanomics, Advantagene, Advanz Pharma, Advaxis, Aegis Therapeutics, Aeglea BioTherapeutics, Aelan Cell Technologies, AEterna Zentaris, Aethlon Medical, Aetna, AffaMed Therapeutics, Affibody, Affigen, Affimed Therapeutics, Affinita Biotech, Affymetrix, Agalimmune, AGC Biologics, Agena Bioscience, Agency for Healthcare Research and Quality, Agendia, Agensys, Agenus Bio, Agilent Technologies, Agilvax, Agios Pharmaceuticals, AG Mednet, AgonOx, Aiforia Technologies, AIMM Therapeutics, Airmed Biopharma, AirXpanders, Aitbiotech, AiVita Biomedical, Akeso Biopharma, Akrevia Therapeutics, Akriveia Therapeutics, Akrivis Technologies, Albert Einstein College of Medicine, Albert Einstein Healthcare Network, Albumedix, Alcami, Alcyone Lifesciences, Aldevron, Alibaba Health, Alion Pharmaceuticals, Alkermes, Allcure Kangtai Proton Technology, Allegheny General Hospital, Allergan, Alliance for Biosecurity, Alliance For Cancer Care, Alliance For Clinical Trials In Oncology, Alliance Global FZ, Alliance Global Group, Alliance Healthcare Services, Alliance Oncology, Allied-Bristol Life Sciences, Alligator Bioscience, Allogene Therapeutics, Ally Bridge Group, Almac Diagnostics, Almac Discovery, Almac Group, Almirall, Alpha Cancer Technologies, Alpha Imaging, Alphamab, Alpine Immune Sciences, Altavant Sciences, Alteogen, Alteris, Altiora, Altor BioScience, Altum Pharmaceuticals, Altus Formulation, Alvogen, Alvotech, Amal Therapeutics, Amaran Biotechnology, Amarantus BioSciences, Amarna Therapeutics, Ambrx, Ambry Genetics, amcure, America’s Choice Provider Network, American Association for Cancer Research, American Brain Tumor Association, American Cancer Society, American College of Radiology, American CryoStem, American Dental Association, American Health Imaging, American Liver Foundation, American Lung Association, American Skin Association, American Society of Clinical Oncology (ASCO), American Society of Human Genetics, AmerisourceBergen, Amgen, Amneal Pharmaceuticals, AmorChem, Amoy Diagnostics, AmoyDx Diagnostics, AMPATH Oncology Institute, Amplitech, Amunix, Anaeropharma, Analogic, Analytical Bio-Chemistry Laboratories, Analytical Biological Services, Anam Hospital, AnaptysBio, Anchiano Therapeutics, Angelini Pharma, Angiex, Angiochem, Angiodynamics, Angle, Angsana Molecular & Diagnostics, AnHeart Therapeutics, Animatrix Capital, ANI Pharmaceuticals, Anixa Biosciences, Annias Immunotherapeutics, Anpac Bio-Medical Science, Antengene, Anthem Bluecross, Anthera Pharmaceuticals, Anthony Nolan, Antigen Express, Antikor Biopharma, Antitope, Apceth, APC Therapeutics, Apeiron Biologics, Aperion Biologics, Apexigen, APG Bio, Aphios, Apobiologix, Apocell, Apogee Biotechnology, Apogenix, ApolloBio, Apollo Hospitals Group, Appistry, Applied BioMath, Aprea, AptaBio Therapeutics, Aptamer Therapeutics, Aptarion biotech, Aptevo Therapeutics, Aptose Biosciences, Aqilion, Aquila BioMedical, Aranda Pharma, Aratana Therapeutics, Aravive Biologics, Arbor Vita, ArcherDX, ARCH Personalized Medicine Initiative, Arc Medical Design, Arcus Biosciences, Areva Med, arGEN-X, argenx, Argos Therapeutics, Ariad Pharmaceuticals, Ariana Pharma, Arisaph Pharmaceuticals, Arix Bioscience, Armas Pharmaceuticals, Armune Bioscience, Arno Therapeutics, AroCell, Aromics, Arquer Diagnostics, ArQule, Array Biopharma, Arrow Diagnostics, Arrys Therapeutics, Artelo Biosciences, Arvinas, Asahi Kasei, Asana Biosciences, Ascenion, Ascentage Pharma, Asia-Pacific Hepatocellular Carcinoma Trials Group, Asieris MediTech, AskAt, AS Kevelt, Aslan Pharma, Aspen Global, Aspen Park Pharmaceuticals, ASPiRA Labs, Aspira Scientific, Aspyrian Therapeutics, Astellas Pharma, Asterias Biotherapeutics, Astex Pharmaceuticals, AstraZeneca, Asuragen, Atara Biotherapeutics, aTen Therapeutics, Athenex, Atlab Pharma, Atlante Biotech, Atomwise, Atossa Genetics, Atrapos Therapeutics, Atreca, Atrin Pharmaceuticals, Atropos Therapeutics, Auburn University, AUM Biotech, Aura Biosciences, Auransa, Aurigene Discovery Technologies, Auron Therapeutics, Aurora BioPharma, Austin Cancer Center, Australian Research Council, Austrian Institute of Technology, Austrianova Singapore, Austrian Research Promotion Agency, Autodesk, Autolus, Autotelic, Avacta, Avant Diagnostics, Avantis Medical Systems, AVEO Oncology, Avera Health, Avera Heart Hospital of South Dakota, Avillion, Avon Foundation, AV Therapeutics, Avvinity Therapeutics, Awamedica, Axela, Axella Research, Axis Therapeutics, Ayala Pharmaceuticals, Aytu BioScience, Azaya Therapeutics, B-MoGen Biotechnologies, Bacit, Baheal Pharmaceutical, Bank of America, Banner Health, Barbara Ann Karmanos Cancer Institute, Baruch S Blumberg Institute, Basilea Pharmaceutica, Batu Biologics, Bausch & Lomb, Bavarian Nordic, Baxalta, Baxter International, Bayer, Bayer Healthcare, Bayer Schering Pharma, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Institute for Immunology Research, Baylor Sammons Cancer Center, BC Platforms, Beactica, Beckman Coulter, Beckman Research Institute of City of Hope, Becton Dickinson, BeiGene, Beike Biotech, Bellicum Pharmaceuticals, Benitec Biopharma, Berg, BerGenBio, Berkeley Lights, Berlin Chemie, Bertech Diagnostics, Bertin Pharma, Besins Healthcare, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, Beyondspring Pharmaceuticals, BGI, BGI Tech Solutions, BGN Technologies, Bial, Biametrics, Bicycle Therapeutics, Bina Technologies, BIND Therapeutics, Bio-Cancer Treatment International, Bio-Connect Diagnostics, Bio-Path, Bio-Techne, Bio-Thera Solutions, bioAffinity Technologies, BioAgilytix, BioAlliance Pharma, biOasis Technologies, BioAtla, Bioblock, BioCad Holding, BioCancell Therapeutics, BioCanRx, Biocartis, BioCat, Biocept, Bioceros, BiocerOX Products, BioChain, BioClones, Biocon, Biocytogen, BioDelivery Sciences, Biodesix, BioDiscovery, Bio Farma, BioFluidica, BioGemex, Biogen, BioGenetics, Biognosys, Biohaven Pharmaceutical Holding, Biohealth Innovation, BioHeart, Biohit, BioInvent, Biokin Pharmaceutical, BioLife Solutions, BiolineRX, BioLizard, Biological Dynamics, Biologics, Biolyse Pharma, Biomarck Pharmaceuticals, BioMarin Pharmaceutical, BioMark Diagnostics, BioMarker Strategies, Biomax Informatics, Biomedical Advanced Research and Development Authority, Biomedical Catalyst Fund (UK), BioMed Realty Trust, BIOMEDX Group, BioMed X Innovation Center, bioMerieux, Biomunex Pharmaceuticals, BioNano Genomics, Bionix, BioNova Cientifica, BioNovion, BioNTech, Biooutsource, Bioprocess Capital Ventures, Biopsy Sciences, BioRap Technologies, BioReference Laboratories, Biosceptre International, Bioscience, BioSense Global, Biostar Pharmaceuticals, Biostem US, Biotech-IgG, Biotech Development Corp, Biotest, Biothera, BioTheranostics, BioTheryX, Biotoscana Farma, BioVaxys, BioVendor, BioVest, Biovica, BioWa, BioXcel, Bioyong, Birdie Biopharmaceuticals, BL&H, Black Swan Research Initiative, Blanver, Blaze Bioscience, BlinkBio, BliNK Biomedical, BliNK Therapeutics, Bliss Biopharmaceutical, Blockchain Global, BloodCenter Of Wisconsin, Bluebee, Bluebird Bio, Blue Buffalo Company, Blue Cross Blue Shield Association, BlueCross BlueShield of Tennessee, Blue Earth Diagnostics, Blueprint Medicines, BMG Pharmaceuticals, BMV Medica, Boehringer Ingelheim, Bone Therapeutics, Bonnie J. Addario Lung Cancer Foundation, Boreal Genomics, Boryung Pharmaceutical, BostonGene, Boston Pharmaceuticals, Boston Scientific, Boston Strategics, Boston University, Bostwick Laboratories, Bpifrance, Bracco Imaging, BrainLAB, Brain Science Foundation, BRCA Foundation, Breast Cancer Research Foundation (BCRF), Breath Diagnostics, BriaCell Therapeutics, BridgeBio Pharma, Brigham and Women’s Hospital, Bristol-Myers Squibb, Bristol-Myers Squibb Foundation, Bristol-Myers Squibb Pakistan, Broad Institute, Brooks Automation, Brown University, Bruce Power, Bruker, BryoLogyx, BSD Medical, BTG, Buck Institute for Age Research, Bukwang Pharmaceuticals, Burning Rock, Butantan Institute, Button Capital, C-Bridge Capital, C-RAD, C-Tri, C3i, C4 Imaging, C4 Therapeutics, C4X Discovery, Caladrius Biosciences, Caliber Imaging & Diagnostics, Calico, Calidi Biotherapeutics, California Institute for Biomedical Research, California Institute for Regenerative Medicine, California Institute of Technology, California Stem Cell, Calithera Biosciences, Calvert Research, Cambridge Epigenetix, Cambridge Major Laboratories, Camino Partnership, Camurus, Can-Fite BioPharma, Canadian Brain Tumour Consortium, Canadian Cancer Society, Canadian Cancer Trials Group, Canadian Institutes of Health Research, CanBas, CANbridge Life Sciences, Cancer Australia, Cancer Genetics, Cancer Immunotherapy Trials Network, CancerLinQ, Cancer Prevention and Research Institute of Texas, Cancer Prevention Pharmaceuticals, Cancer Research Institute, Cancer Research Society, Cancer Research Technology, Cancer Research UK, Cancer Science Institute of Singapore, Cancer Targeted Technology, Candela, Cannabics Pharmaceuticals, Cannabis Science, CannaKids, Cantargia, Cantex Pharmaceuticals, Cantonal Hospital, CAO Pharmaceuticals, Capellabio, Capital X-ray, Caprion Proteomics, Cardiff University, Cardinal Health, Care GB Plus, Carestream Health, Caris Life Sciences, Carisma Therapeutics, Carna BioSciences, Carnegie Mellon University, Carolina BioOncology Institute, Carolinas Medical Center (CMC), Carrick Therapeutics, CARsgen, Cartagenia, CarThera, Cartherics, Casebia Therapeutics, Case Western Reserve University, CASI Pharmaceuticals, Catalan Institute of Nanotechnology (ICN), Catalent Pharma Solutions, Catalyst Pharmaceutical Partners, Catapult Therapy TCR, Catholic University Leuven, CBD Vida, CBLPath, CBT Pharmaceuticals, CDI Laboratories, CDISC, CDx Diagnostics, CEA-Leti, Cedars-Sinai Medical Center, CeGaT, CEITEC, Celdara Medical, Celgene, CellAct, Cellaria Biosciences, Cell Design Labs, Celldex Therapeutics, Cellectar Biosciences, Cellect Biotechnology, Cellectis, Cellerant Therapeutics, Cellesce, CellforCure, Cellgen Diagnostics, Cell Line Genetics, CellMark Medical, Cell Medica, Cell Mogrify, CellSight Technologies, Cell Signaling Technology, Cell Therapy Catapult, Cellth Systems, Celltrion, Cellular Biomedicine, CeloNova BioSciences, Cel Sci, Celsee, Celsion, Celsius Therapeutics, Celtic Biotech, Celyad, Centauri Therapeutics, Centene, Center for Biomarker Research in Medicine, Center for Cancer Research, Center for Connected Health, Center for iPS Cells Research and Application, Centogene, Centre de Recherche en Cancérologie de Lyon, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Drug Design and Discovery, Centre for Drug Research and Development (CDRD), Centre for Imaging Technology Commercialization, Centre for Probe Development and Commercialization, Centre For The Commercialization Of Antibodies And Biologics, Centre Hospitalier Universitaire Vaudois (CHUV), Centre Hospital University - Bordeaux, Centre Leon Berard, Centre National de Biologie Expérimentale, Centro de Inmunolgía Molecular, Century Therapeutics, Cerba HealthCare, Ceres, Cernostics, Certis, Cerulean Pharma, Cevec Pharmaceuticals, cGMP Validation, Champalimaud Foundation, Champions Oncology, Changzhou Le Sun Pharmaceuticals, Charles River Laboratories, Checkmate Pharmaceuticals, CheckPoint Immunology, Checkpoint Therapeutics, Chembio Diagnostics, ChemImage, Chemveda Life Sciences, ChemWerth, Cheplapharm Arzneimittel, Chi-Med, Children’s Cancer Institute Australia for Medical Research, Children’s Cancer Therapy Development Institute, Children’s Hospital Boston, Children’s Hospital Los Angeles, Children’s Hospital of Orange County, Children’s Hospital of Philadelphia, Children’s Medical Research Institute, Children’s Minnesota, Chimerix, China-Singapore Guangzhou Knowledge City, China Isotope And Radiation, China Medical System, China Oncology Focus, China Resources Guokang Pharmaceuticals, China State Institute of Pharmaceutical Industry (CIPI), Chinese Future Industry Investment Fund, Chiome Bioscience, Chiromics, Cholangiocarcinoma Foundation, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, Chongqing Lummy Pharma, Chonnam National University, Christian Doppler Research Association, Chroma Therapeutics, Chrysalis BioTherapeutics, Chugai Pharmaceutical, Chugai Pharma Marketing, Ciitizen, Cilag AG, CiMaas, CIMAB SA, Cincinnati Children’s Hospital Medical Center, Cinda Bio-Pharmaceutical, Cipher Pharmaceuticals, Cipla, Cipla Medpro, Circuit Clinical, Circulogene, Cirrus Dx, Cisbio Bioassays, Cisen Pharma, Citron Pharma, City of Hope, City of Hope Comprehensive Cancer Center, CivaTech Oncology, CIVCO Radiotherapy, CJ Corp, Clal Biotech, Clalit Health Fund, Clarient, Clarity Pharmaceuticals, Clarius Mobile Health, Cleara Biotech, Clearbridge Biomedics, ClearLight Diagnostics, Clearside Biomedical, ClearView Diagnostics, Cleveland BioLabs, Cleveland Clinic, Cleveland Diagnostics, Cleveland University Hospitals, Clevexel Pharma, Clinatec, Clinical Genomics, Clinical Laserthermia Systems (CLS), Clinical Network Services, Clinical Oncology Research Excellence (CORE), Clinical Outcomes Tracking and Analysis, Clinica Universidad Navarra, Clinigen, Clinipace Worldwide, Clinton Health Access Initiative, Cloaked Therapeutics, CloudHealth Genomics, Cloud Pharmaceuticals, Clovis Oncology, CMAB Biopharma, CMC Biologics, Co-Diagnostics, Cobalt Healthcare Consultants, Cobra Biologics, Codiak BioSciences, Cofactor Genomics, Cold Genesys, Cold Spring Harbor, Coldstream Laboratories, Collegium Pharmaceuticals, Color, Colorado State University, Color Genomics, Columbia University, Columbia University Medical Center, Comed Medical Specialties, Common Sense, Community Medical Center, CompanionDx Reference Lab, Complix, Compugen, Concerto HealthAI, Concile, Concordia Healthcare, Congenica, Conkwest, Constance Therapeutics, Context Therapeutics, Contextual Genomics, ContraVir Pharmaceuticals, ConverGene, Cook Biotech, Coqui RadioPharmaceuticals, Corcept Therapeutics, Corden Pharma, Core Diagnostics India, Cornell University, Coronado Biosciences, Corvida Medical, Corvus Pharmaceuticals, COTA, Covalab, Covance, Covidien, Covis Pharmaceutical, Crescendo Biologics, Crescendo Bioscience, Crestar Labs, CRISPR Therapeutics, Cristal Therapeutics, Croix-Rousse Hospital, Crown Bioscience, Crown Dental + Medical, CR Pharma, CRT Pioneer Fund, CryoPort, CrystalGenomics, CSC Pharmaceuticals, CSI Laboratories, CSIRO, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTI BioPharma, Cullinan Oncology, Cumberland Pharmaceuticals, Cumulus Oncology, Curadev Pharma, Cure Brain Cancer Foundation, Cure Forward, CURE Pharmaceutical, Cures Within Reach, CureTech, CureVac, Curie-Cancer, Curing Kids Cancer, Curis, Curium, Curtana Pharmaceuticals, Cutaneous Lymphoma Foundation, CvergenX, CyberKnife, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cyclica, Cyclopharm, Cyclotek, Cynata Therapeutics, Cyntec, Cynvenio, Cyteir Therapeutics, CytImmune Science, CYTLIMIC, Cytodyn, CytoLumina Technologies, CytomX Therapeutics, Cytori Therapeutics, Cytos Biotechnology, CytoSen Therapeutics, CytoSorbents, Cytovance Biologics, Cytovation, CytRx, D&K Technologies, D-Eye, Daiichi Sankyo, Dainippon Sumitomo Pharma, Dako, Dana-Farber Cancer Institute, DanDrit Biotech, Danish Center for Strategic Research into Type 2 Diabetes, Dartmouth-Hitchcock Medical Center, Dartmouth College, DaRui Biotech, DarwinHealth, Dauntless Pharmaceuticals, David H. Koch Institute for Integrative Cancer Research, DaVita Clinical Research, Davospharma, DCPrime, Debiopharm, Deciphera Pharmaceuticals, Decipher Biosciences, DecisionQ, deCODE Genetics, de Duve Institute, DEEP 6 AI, Deep Lens, Deerfield Management, Definiens, DeGregorio Family Foundation, Delcath Systems, Dell, DelMar Pharmaceuticals, DelSiTech, Dendreon, Denka, Denka-KEW Genomics, Denovo Biopharma, Densitas, Dentamed, Department of Defense, Department of Energy, Department of Health and Human Services, Department of Veterans Affairs, DePuy, Desktop Genetics, Device Technologies, Devicor Medical Products, Devonian Health Group, Dexcel Pharma, DiaCarta, DiagnoCure, Diagnoplex, Diagnostica Longwood, Diagnostic Oncology Contract Research Organization, DiaMedica, Diatheva, Dilon Diagnostics, DiNonA, Distributed Bio, Dizal Pharmaceutical, DNAmito, DNA Therapeutics, DNAtrix, Domainex, Domain Therapeutics, Dong-A ST, Dorizoe Lifesciences, Dr. Reddy’s Laboratories, Dr. Susan Love Research Foundation, Dragonfly Therapeutics, Dr Allen Wu, Dresner Foundation, Drexel University, DRI Capital, Dr Risch, Drukier Institute for Children’s Health, DSG, Dual Therapeutics, DuChemBio, Duke-NUS Graduate Medical School Singapore, Duke Cancer Institute, Duke University, Duke University Medical Center, Dune Medical Devices, Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON), DxM Diagnostico Molecular, DxTerity, DyNAbind, Dynavax Technologies, DySIS Medical, E3x Bio, Eagle Pharmaceuticals, Eastern Cooperative Oncology Group, Easton Pharmaceuticals, Eckert & Ziegler, ECOG-ACRIN Cancer Research Group, Eddingpharm, Eden BioCell, Edico Genome, EdiGene, Edinburgh Molecular Imaging, Editas Medicine, Edogawa Hospital, EDP Biotech, Educational and Scientific, eFFECTOR Therapeutics, Egenix, EhmetDx, Eigen, Eiger BioPharmaceuticals, EIP Eczacibasi Ilac Pazarlama, EirGenix, Eisai, Eisai Inc, EKF Diagnostics, Elanco, ELC Group, Elekta, Eleven Biotherapeutics, Eli Lilly, Elligo Health Research, Elpis Biomed, Elpiscience, ElsaLys Biotech, Elthera, Elucidata, Embleema, Emcure Pharmaceuticals, EMD Millipore, EMD Serono, Emerge Health, Emergent BioSolutions, EMMAC Life Sciences, Emory University, Emtora Biosciences, Emulate, Enamine, Encycle Therpaeutics, Endocare, Endocyte, Endo International, Endomag, Endomagnetics, Endo Pharmaceuticals, Endotronix, EnGeneIC, Enigma Biomedical, Enlibrium, ENPICOM, Enterome Bioscience, Entrinsic Health Solutions, Enumeral Biomedical, Enzo Biochem, Enzo Clinical Labs, Enzyvant Science, Epic Sciences, Epigenomics, EpimAb Biotherapeutics, EpiThany, Epizyme, Erasmus University Medical Center, Erytech, Esophageal Cancer Awareness Association, Especificos Stendhal, Esperance Pharmaceuticals, Essex Bio-Technology, eTheRNA immunotherapies, Ethicann Pharmaceuticals, Etubics, Euclises Pharmaceuticals, Eureka Eurostars, Eureka Therapeutic, Eurobio, Eurofarma, Eurofins STA Laboratories, European Commission, European Health Centre Innovation, European Infrastructure for Translational Medicine, European Medical Contract Manufacturing, European Organization for Research and Treatment of Cancer, European Society for Radiotherapy & Oncology, European Union, European Union Regional Development Fund, EUSA Pharma, Eutilex, Eutropics Pharmaceuticals, Evelo Biosciences, Event Cardio Group, Everest Medicines, Everything Genetic, Evotec, Evvivax, Ewopharma, Exact Imaging, Exactis Innovation, Exact Sciences, Exelixis, Exiqon, Exosome Diagnostics, Exosome Sciences, Exovita Biosciences, Expression Analysis, ExScientia, F-Star, F-Star Alpha, F1 Oncology, Fabric Genomics, Facit, FairJourney Biologics, Faron Pharmaceuticals, Fate Therapeutics, Faulk Pharmaceuticals, Federal Ministry of Education and Research (BMBF), FedMed, Feinstein Institute for Medical Research, Feist-Weiller Cancer Center, Feldan Therapeutics, Felicitex Therapeutics, Femasys, Femtogenix, Ferring Pharmaceuticals, FetoLumina Technologies, FGH Biotech, Finnish Funding Agency for Technology and Innovation (TEKES), Firebrand Therapeutics, FitBit, Five Prime Therapeutics, FKD Therapies, Flatiron Health, Flemish agency for Innovation by Science and Technology, Flow Pharma, Fluxion Biosciences, FLX Bio, FNApath, Focal Healthcare, Folia Biotech, Fondation Cancer, Fondatioun Kriibskrank Kanner, Food and Drug Administration (FDA), Forbius, Foresee Pharmaceuticals, FORMA Therapeutics, Fortified Provider Network, Fortress Biotech, Forty Seven, Fosun Pharmaceutical, Foundation Medicine, Fox Chase Cancer Center, Francis Crick Institute, Fraunhofer IGB, Fraunhofer Institute for Microelectronic Circuits and Systems, Fred & Pamela Buffett Cancer Center, Frederick National Laboratory For Cancer Research, Fred Hutchinson Cancer Research Center, Freenome, French National Research Agency, Fresenius Medical Care, Frontida BioPharm, Fscan, Fudan University, Fuhong Hanlin, Fujifilm, Fuji Pharma, Fujirebio Diagnostics, Fusion Antibodies, G-TAC, G1 Therapeutics, Gadeta, Galaxy Biotech, Galaxy Health Network, Galectin Sciences, Galectin Therapeutics, Galena Biopharma, Gallus Biopharmaceuticals, GamaMabs Pharma, Gamida Cell, GammaDelta Therapeutics, Gamma Medica, Gateway for Cancer Research, GC LabCell, GC Pharma, GE Healthcare, Geisel School of Medicine at Dartmouth, Geisinger Health System, Gem Pharma, Gen-Probe, Gen9, Genclis, Genecast, GeneCentric Therapeutics, GeneData, GeneInsight, GeneNews, Genentech, Geneos Therapeutics, GeneQuantum Healthcare, Generex Biotechnology, GeneSegues, GenesisCare, Genetic Immunity, Genetic Technologies, Genevant Sciences, Genexine, Gen Ilac, Genisphere, Genmab, Genocea Biosciences, Genomac Research Institute, Genome Canada, GenomeDx, Genome Institute of Singapore, Genomeon, GenomiCare, Genomic Health, Genomics England, Genomic Testing Cooperative, Genomic Vision, Genomoncology, Genoptix, Genor Biopharma, Genprex, GenSpera, GenVec, Genzyme, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Georgetown University Hospital, George Washington University, Georgia Institute of Technology, Georgia Regents University in Augusta, Georgia State University, GeoVax, German Cancer Research Center, German Ministry for Education and Research, Geron, Gestion Univalor, Gilead Sciences, GIMDx, Giorgio Foundation, GISCAD Foundation, Glactone Pharma, Gland Pharma, GlaxoSmithKline, Glenmark Pharmaceuticals, GLG Pharma, Glide, Global Cancer Diagnostics, Global Discovery Biosciences, Global Lung Cancer Coalition, Global Medical Solutions, Globavir Biosciences, Gloval Specimen Solutions, GlycoMimetics, Glycostem Therapeutics, Glycotest, Glycotope Biotechnology, Glycyx Pharmaceuticals, Glythera, Gnosis Bioresearch, GNS Healthcare, GNYHA Services, GOG Foundation, Goodwin Biotechnology, Gotect Diagnostic, GO Therapeutics, Government of Canada, Gradalis, Grady Health System, Grail, Gray Foundation, Greater Paris University Hospitals, Green Cross LabCell, Greenville Health System, Grid Therapeutics, Gritstone Oncology, Group Vida, GRU Cancer Center, Grunenthal, Grupo Ferrer, GRYT Health, GT Apeiron Therapeutics, GT Biopharma, GTx, Guangzhou Institute of Biomedicine and Health, Guangzhou Xiangxue Pharmaceutical, Guardant Health, Guerbet, Guided Therapeutics, Guided Therapy Systems, GuideVine, GVK Biosciences, GW Pharmaceuticals, H-Immune, H3 Biomedicine, Hackensack Meridian Health, Hackensack University Medical Center, Hadasit Medical Research Services and Development, Hadassah Medical Center, Haga Teaching Hospital, Hainan Sihuan Pharmaceutical, Hainan Sinotau Pharmaceutical, HalioDx, Halozyme Therapeutics, Hamilton Health Sciences, Hanmi Pharmaceutical, Hannover Medical School, HanX Biopharmaceuticals, Hapten Sciences, Harbour Biomed, Harpoon Therapeutics, Harvard Medical School, Harvard Pilgrim Health Care, Harvard University, Hauptman-Woodward Medical Research Institute, HD Biosciences, Health Canada, Healthcare Global Enterprises, Healthcare Royalty Partners, Healthcare Technology Innovation Centre (Chennai), Health Diagnostics Laboratory, HealthMyne, HealthTrust, Heat Biologics, Hebrew University of Jerusalem, Hefei Sageland Biotechnology, Heidelberg Pharma, Helen F Graham Cancer Center, Helix BioPharma, Helmholtz Zentrum Munchen, Helomics, Helsinki University Central Hospital (HUCH) Comprehensive Cancer Center, Helsinn Healthcare, Helsinn Therapeutics, HemCon Medical Technologies, HemispheRx Biopharma, Hemogenomics Pharma, Henlius Biotech, Henry Ford Health System, Henry M. Jackson Foundation, Herlev Hospital, HiFiBio, Highline Therapeutics, Highmark Blue Shield, Highmark Health, Hikma Pharmaceuticals, Himed Hospital Management, Histogen, Histogenics, Histogen Oncology, Hitachi, Hitachi Aloka Medical, Hitachi Chemical, Hitachi Medical Systems Europe, HitGen, Hoag Memorial Hospital Presbyterian, Hoffmann La Roche, HollandPTC, Hologic, Hong Kong Polytechnic University, Honor, Hookipa Biotech, Hoosier Cancer Research Network, HOPE BIOSCIENCES, Hope for Stomach Cancer, Horizon 2020, Horizon Discovery, Horizon Healthcare Services, Horizon Pharma plc, Hospira, Hospital del Mar, Hospital Services, Hoth Therapeutics, HTG Molecular Diagnostics, Hubrecht Organoid Technology, HudsonAlpha Institute for Biotechnology, Humana, Humanetics, Humanigen, Human Longevity, Human Vaccines Project, Hummingbird Bioscience, Huntsman Cancer Foundation, Huntsman Cancer Institute, Huons, Hutchison MediPharma, HUYA Bioscience, Hvidovre Hospital, Hy BioPharma, Hybridyne Imaging Technologies, Hyundai Hope On Wheels, Hyundai Pharmaceutical, I-mab, i2 Pharmaceuticals, IBA, IBA Molecular Imaging, Ibex Medical Analytics, iBIO Institute’s PROPEL Center, IBL America, IBM, IBM Watson Health, iCAD, Icahn School of Medicine at Mount Sinai, IceCure Medical, Ichor Medical Systems, Icon, Iconic Therapeutics, IDB Resources, iDD Biotech, IDEAYA Biosciences, Idengene, Idera Pharmaceuticals, Idorsia, IDT, iGEM, Igenica, IGNITE Immunotherapy, Ignyta, Iksuda Therapeutics, Ilera Therapeutics, Illumina, Image Analysis, ImaginAb, Imaging Associates, Imanis Life Sciences, ImCheck Therapeutics, ImClone Systems, Imegen, Immatics Biotechnologies, Immatics US, Immodulon Therapeutics, Immune-Onc Therapeutics, Immune Biosolutions, Immune Design, ImmuneOncia, Immune Pharmaceuticals, Immune Therapeutics, ImmunGene, Immunicum, ImmunID Technologies, Immunitor, ImmunoBiochem, ImmunoCellular Therapeutics, ImmunoChina Pharmaceuticals, Immunocore, ImmunoForge, ImmunoGen, Immunome, Immunomedics, Immunomic, ImmunoPhotonics, Immunovaccine, Immunovia, Immunscape, Immusol, Immutep, IMPACT Therapeutics, Imperial College London, Imperial Innovations, Impilo Pharma, IMS Health, Imugene, IMV, IncellDx, INC Research, Incuron, Incyte, Indee Labs, Indiana University, Indian Cooperative Oncology Network, Indigo Biosciences, Indivumed, Industrial Technology Research Institute, Infinity Pharmaceuticals, Inflection Biosciences, Inform Genomics, Infuseon Therapeutics, InfuSystem Holdings, Inhibitor Therapeutics, Inhibrx, Inivata, INmune Bio, Innate Pharma, Innocrin Pharmaceuticals, Innoplexus, Innovate UK, Innovative Diagnostic Laboratory, Innovative Genomics Initiative (IGI), Innovative Immunotherapy Alliance, Innovative Targeting Solutions, Innovent Biologics, InnoVision Therapeutics, Innovus Pharmaceuticals, In Ovations Holdings, Inovio, Inovio Pharmaceuticals, Inserm, Inserm Transfert, InSightec, Insight Genetics, Insight Medical Systems, InSphero, Inspyr Therapeutics, Instillo, Institut Català d’Oncologia, Institut Curie, Institute for Bioscience and Biotechnology Research, Institute for Myeloma and Bone Cancer Research, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for Systems Biology, Institute for the Promotion of Innovation by Science and Technology in Flanders, Institute of Bioengineering of Catalonia, Institute of Biophysics, Institute of Cancer Research, Institute of Genetics and Molecular and Cellular Biology, Institut Gustave Roussy, Instituto Diagnostico Varelli, Instituto Valenciano De Oncologia, Institut Pasteur, Insys Therapeutics, IntegraGen, Integral Molecular, Integrated Biobank of Luxembourg, Integrated Diagnostics, Integrated DNA Technologies, Inteliquet, Intellia Therapeutics, Intensity Therapeutics, Intermountain Healthcare, International Association for the Study of Lung Cancer, International Isotopes, International Myeloma Foundation, Interpace Diagnostics, Interpace Diagnostics Group, Intezyne, IntraMed, Intrexon, Intuitive Surgical, INVAP, Invectys, Invenra, InventisBio, Inventiva, inVentiv Health, Invetech, inviCRO, Invitae, InVivoScribe, IO Biotech, Ionis Pharmaceuticals, ION Solutions, IONTAS, Iovance Biotherapeutics, iOx Therapeutics, Ipca Laboratories, iPharma, IPMD, iProgen Biotech, Iproteos, Ipsen, iQ Group, IRBM, IriSys, IROA Technologies, Ironwood Pharmaceuticals, IRX Therapeutics, ISA Pharmaceuticals, Isarna Therapeutics, ISIS Innovation, Isla Lab Products, Isofol Medical, IsoPlexis, IsoRay, IsoTherapeutics, Isotope Technologies Garching, Israeli Ministry of Industry and Commerce, Israeli National Authority for Technological Innovation, Istituto Diagnostico Varelli, Item, ITEM Medical Technologies, i